More than 50 years of landmark results
Since 1967, Lowey Dannenberg has represented investors and major corporations in complex litigation, recovering billions of dollars on their behalf.Solutions for Complex Cases
Professional Recommendations
Recent Cases

Generic Pharmaceuticals Price Fixing
Antitrust, Health Care, Healthcare
Lowey Dannenberg represents 34 of the nation’s largest health insurers, including Elevance Health (formerly known as Anthem), Aetna, Humana, and 25 BlueCross BlueShield licensees in connection with their claims relating […]

Swiss Franc LIBOR
Antitrust
Lowey Dannenberg is the court-appointed sole lead counsel in a class action against numerous global financial institutions responsible for setting the London Interbank Offered Rate for the Swiss Franc (Swiss […]

Euribor
Antitrust
Lowey Dannenberg is leading the prosecution against the global financial institutions responsible for the setting of the Euro Interbank Offered Rate (“Euribor”), a global reference rate used to benchmark, price […]
News
Lowey Dannenberg Appointed Co-Lead Counsel in Lumen Technologies, Inc. Stockholder Derivative Litigation
On April 21, 2025, Hon. Kayla D. McClusky, United States Magistrate Judge, appointed Lowey Dannenberg, P.C. as the Co-Lead counsel representing Plaintiffs and a proposed class in the consolidated action: In re Lumen Technologies, Inc. Stockholder Derivative…
Blog
Don’t Press Replay: Third Circuit Rules in Favor of User Privacy with Popa Decision
In August 2022, the Third Circuit handed down a decision addressing both exceptions to and the definition of “intercept” under the Pennsylvania Wiretapping and Electronic Surveillance Control Act (WESCA).[1] Popa v. Harriet Carter Gifts, Inc. , 45 F. 4th 687 (3d Cir. 2022), reh’g granted and…





